微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 53.32% | 2.21% | -1.86% | 70/141 | 52.4% | 佰仁医疗 | 88.71% | 行业排名> |
| 2026-03-31 | 54.33% | 9.62% | 2.65% | 69/141 | 52.37% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 52.93% | 9.5% | 1.07% | 67/141 | 51.9% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 52.37% | 2.81% | 0.39% | 70/141 | 52.23% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 52.17% | 1.67% | 5.25% | 71/141 | 52.48% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 49.57% | -4.22% | 2.53% | 74/141 | 52.13% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 48.34% | 5.22% | -5.1% | 82/141 | 53.08% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 50.94% | 10.05% | -0.72% | 74/141 | 53.87% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 51.31% | 11.31% | -0.84% | 73/141 | 53.95% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 51.75% | 10.05% | 12.63% | 68/141 | 53.88% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 45.94% | 10.35% | -0.75% | 85/141 | 53.57% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 46.29% | 15.9% | 0.41% | 82/141 | 54.44% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 46.1% | 11.54% | -1.96% | 82/141 | 53.81% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 47.02% | 2% | 12.94% | 81/141 | 54.06% | 万泰生物 | 91.61% | 行业排名> |
| 2022-12-31 | 41.63% | -3.72% | 4.25% | 95/141 | 54.01% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 39.94% | 2% | -3.36% | 93/141 | 55.7% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 41.33% | -14.98% | -4.43% | 96/141 | 55.37% | 三友医疗 | 90.29% | 行业排名> |
| 2021-12-31 | 43.24% | -33.34% | -11.04% | 99/141 | 57.98% | 三友医疗 | 90.73% | 行业排名> |
| 2021-06-30 | 48.61% | -32.95% | -25.07% | 82/141 | 59.05% | 三友医疗 | 90.5% | 行业排名> |
| 2020-12-31 | 64.87% | 32.72% | -10.52% | 59/141 | 60.12% | 三友医疗 | 90.29% | 行业排名> |
| 2020-06-30 | 72.5% | 2% | 48.32% | 29/141 | 60.36% | 正海生物 | 90.78% | 行业排名> |
| 2019-12-31 | 48.88% | 2.21% | 2.21% | 74/141 | 56.96% | 正海生物 | 91.59% | 行业排名> |
| 2018-12-31 | 47.82% | 1.67% | 1.67% | 69/141 | 56.22% | 正海生物 | 92.23% | 行业排名> |
| 2017-12-31 | 47.04% | 2% | 2% | 65/141 | 56.1% | 正海生物 | 92.69% | 行业排名> |